San Antonio Report: Can 3 existing drugs slow aging? UT Health San Antonio prepares major study to find out.
March 16, 2026
San Antonio Report: Can 3 existing drugs slow aging? UT Health San Antonio prepares major study to find out.
Large rapamycin clinical trial launches at UT Health San Antonio
March 16, 2026
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.
UT San Antonio to lead $38 million national trial testing drugs to extend healthspan
March 4, 2026
The Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, will receive up to $38 million to lead a national clinical trial funded by the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services.
Kraig named Distinguished Fellow of the American Association of Immunologists
February 18, 2026
Ellen Kraig, PhD, professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresea Lozano Long School of Medicine at the University of Texas at San Antonio (UT San Antonio), has been named a Distinguished Fellow of the American Association of Immunologists (AAI). The AAI Distinguished Fellow designation recognizes members with […]
Texas Public Radio: The Source — The new front line in the science of aging
January 26, 2026
Texas Public Radio: The Source — The new front line in the science of aging
Researchers explore genetic roots, new diagnostic tools for early-onset dementia
January 15, 2026
Dementia is one of the most challenging medical and societal issues of our time, affecting memory, thinking and independence for millions of families worldwide. At UT Health San Antonio, researchers and clinicians are taking new steps to change that story through research, genetic insights and compassionate, integrated care. At the heart of this mission is […]